The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Faeth Therapeutics
Honoraria - Novartis
Consulting or Advisory Role - Bridgebio; Faeth Therapeutics; Novartis; Scorpion Therapeutics
Research Funding - Pfizer
Patents, Royalties, Other Intellectual Property - Faeth Therapeutics; Weill Cornell Medical College
Targeting insulin feedback to enhance alpelisib (TIFA): A phase II randomized trial in metastatic, PIK3CA-mutant, hormone receptor–positive breast cancer.
 
Sherry Shen
Honoraria - MJH Life Sciences
 
Erica Salehi
No Relationships to Disclose
 
Azeez Farooki
Stock and Other Ownership Interests - Johnson & Johnson
Consulting or Advisory Role - Novartis
 
James Flory
No Relationships to Disclose
 
Dominiq Williams
No Relationships to Disclose
 
Andrea Carpio
No Relationships to Disclose
 
Cassandra Chang
No Relationships to Disclose
 
Mario E. Lacouture
Stock and Other Ownership Interests - Oncoderm (I)
Honoraria - Apricity Health; AstraZeneca; Deciphera; Incyte; Innovaderm; Janssen; L'Oreal; La Roche-Posay; Lutris; MJH Associates; Nanology; Novartis; Novocure; OnQuality Pharmaceuticals; RBC consultants; Relay Therapeutics; Roche/Genentech; Seattle Genetics/Astellas; Tyra Biosciences
Consulting or Advisory Role - Apricity Health; AstraZeneca; Deciphera; Genentech; Incyte; Innovaderm; Janssen Research & Development; La Roche-Posay; Lutris; Novartis; Novocure; OnQuality Pharmaceuticals; Relay Therapeutics; Roche; Roche; Seagen; Tyra Biosciences
Research Funding - AstraZeneca/MedImmune (Inst); Columbia University (Inst); Lutris; National Jewish Health (Inst); Novartis (Inst); Novocure; Paxman; US Biotest
Other Relationship - Oncoderm (I)
(OPTIONAL) Uncompensated Relationships - Oncoderm
 
Eleni Andreopoulou
No Relationships to Disclose
 
Sagar D. Sardesai
Honoraria - bioTheranostics; Immunomedics; Novartis
Consulting or Advisory Role - Novartis
Speakers' Bureau - Immunomedics
Travel, Accommodations, Expenses - Novartis
 
Komal L. Jhaveri
Consulting or Advisory Role - Abbvie; AstraZeneca; Biotheranostics; BluePrint Medicines; Bristol-Myers Squibb; Daiichi Sankyo; Genentech; Intellisphere; Jounce therapeutics; Lilly; Novartis; Pfizer; Sanofi; Seagen; Sun Pharma Advanced Research Company; Synthon; Taiho Oncology
Research Funding - ADC Therapeutics (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Debiopharm Group (Inst); Genentech (Inst); Immunomedics (Inst); Lilly (Inst); Novartis (Inst); Novita Pharmaceuticals (Inst); Pfizer (Inst); Puma Biotechnology (Inst); VelosBio/Merck (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Intellisphere; Jounce Therapeutics; Pfizer; Taiho Pharmaceutical
 
Lewis Clayton Cantley
Leadership - Bristol Myers Squibb Foundation (I); Denali Therapeutics (I); Faeth Therapeutics; VIR Biotechnology (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb (I); Denali Therapeutics (I); Faeth Therapeutics; VIR Biotechnology (I)
Honoraria - Agios; Novartis; Pfizer
Consulting or Advisory Role - Agios; Novartis; Pfizer
Research Funding - Sanofi
Patents, Royalties, Other Intellectual Property - Faeth Therapeutics; Larkspur; Petra-Loxo-Lily; Pfizer; Volastra Therapeutics
 
Marcus D. Goncalves
No Relationships to Disclose
 
Neil M. Iyengar
Consulting or Advisory Role - Novartis; Seagen
Research Funding - American Cancer Society (Inst); Breast Cancer Research Foundation (Inst); Conquer Cancer Foundation (Inst); National Cancer Institute (Inst); Novartis (Inst)